Decera Clinical Education Infectious Disease Podcast
Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Decera Clinical Education. Gain practical strategies and earn CME/CE credit for selected episodes.
Treatment of Refractory/Resistant CMV in HCT Recipients: Optimizing Transplant Outcomes Through Contemporary CMV Management
Cytomegalovirus (CMV) infection is one of the most significant infectious complications after hematopoietic cell transplant (HCT), but there have been major advances in CMV management to date. In this podcast, featuring curated audio from a live satellite symposium, experts Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID, and Marcus Pereira, MD, MPH, FAST, discuss considerations for CMV treatment in HCT recipients and examine treatment options for refractory/resistant CMV.
Topics include:
Considerations for CMV management in HCT recipients New definitions of refractory and resistant CMV Risk factors for refractory and resistant CMV infections Identifying drug-resistant CMV Tr...Managing CMV Risk in HCT Recipients: Optimizing Transplant Outcomes Through Contemporary CMV Management
Cytomegalovirus (CMV) infection is one of the most significant infectious complications after hematopoietic cell transplant (HCT). In this podcast, featuring curated audio from a live satellite symposium, experts Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID and Marcus Pereira, MD, MPH, FAST, discuss the burden of CMV in HCT recipients and explore strategies effectively identify and monitor high-risk patients. Topics include:
Epidemiology of CMV among HCT recipients Direct and indirect effects of CMV after HCT Dynamics of risk factors for CMV infection Strategies for prevention of CMV infectionTo view the full educational program and download the a...
Shingles Solutions Podcast: Strategies for Improving Vaccine Uptake and Series Completion
In this podcast, experts Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPH; Ruth Carrico, PhD, DNP, FNP-C, FAAN; and Dalilah Restrepo, MD, discuss improving shingles vaccine uptake. Topics covered include:
The Burden of ShinglesCare Coordination Between Primary and Specialty CarePromoting Shingles Vaccine Series CompletionAddressing Disparities in Shingles Vaccine Access and Uptake
Presenters:
Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPH
Associate Professor of Clinical Pharmacy
University of California, San Diego
Department of Pharmacy Practice and Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences
Division of the Black Diaspora and African American Studies
La Jolla, Cali...
Setting Our Sights on Symptom Management: Raising the Bar in PBC Management Podcast
Historically, key symptoms of primary biliary cholangitis (PBC), such as pruritus and fatigue, have been understudied and undertreated. Listen now to learn how symptom management should be considered independently of PBC management, and how new therapeutic agents can help.
Topics covered include:
Mechanisms of pruritus and fatigue in PBCNonpharmacologic treatment optionsAn overview of clinical trial data supporting second-line agents for symptom management:BezafibrateElafibranorSeladelparInvestigational agents:VolixibatLinerixibatSetanaxibThis episode is the third of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite s...
Second-line Agents for Achieving Treatment Goals: Raising the Bar in PBC Management Podcast
New therapeutic agents for second-line treatment are raising the bar for primary biliary cholangitis (PBC) management. Listen now to learn how to incorporate these new agents into clinical practice and how these agents will impact attainment of treatment goals.
Topics covered include:
Available agents for second-line treatment of PBCAn overview of clinical trial data supporting second-line agents:Obeticholic acid (OCA)BezafibrateElafibranorSeladelparThis episode is the second of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download t...
Defining Our Treatment Goals: Raising the Bar in PBC Management Podcast
Advancements in our understanding of primary biliary cholangitis (PBC) and new therapeutic agents have reshaped the care landscape of PBC. Listen now to learn how these developments are helping to redefine and elevate treatment goals. Topics covered include:
How and when to assess treatment responseRisk factors in PBCBiochemical treatment response and fibrosis stage as predictors of transplant-free survivalDynamics of liver stiffness measurements and clinical outcomes in PBCThe importance of bilirubin and alkaline phosphatase normalizationThis episode is the first of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For t...
Keeping Up With New Developments in PBC
Tune in to listen as expert faculty, Dr Christopher L. Bowlus and Dr Sonal Kumar, discuss recent developments in treating primary biliary cholangitis (PBC) with new and emerging agents, as well as strategies to integrate these advances into clinical practice.
Topics covered include:
Methods of Assessing PBC Disease ProgressionNewer Agents for Second-line Treatment of PBCPrioritizing Symptom Management and Quality of Life With PBC TreatmentPresenters:
Christopher L. Bowlus, MD
Lena Valenta Professor and Chief
Division of Gastroenterology and Hepatology
School of Medicine
University of California Davis
Sacramento, California
Key PBC Studies From AASLD 2025 Podcast
Listen in as Nancy Reau, MD, reviews key highlights of the most impactful primary biliary cholangitis (PBC) research and gain insights on how to apply these new advances to clinical practice.
Topics covered include:
Treatment GoalsLong-term Data With PPAR AgonistsInvestigational Therapies for PruritusPresenter:
Nancy Reau, MD
Professor of Medicine
Richard B. Capps Chair of Hepatology
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Rush University Medical Center
Chicago, Illinois
To download the accompanying slides, visit the program page for this episode:
https://bit...
Patient Perspectives on New Developments in PBC: Individualizing Patient Care Podcast
Recent advances in primary biliary cholangitis (PBC) care have resulted in a new focus on personalized care and symptom management. Tune in to learn from patient advocate, Maria G. Morais, RN, how you can integrate patient insights and priorities into treatment plans for PBC. Topics covered include:
The Canadian PBC Society Survey: Comorbidities and Treatment GoalsDefining and Achieving Goal-Driven Care for PBCRecent Advances in PBC ManagementNewer Agents for Second-line Treatment of PBCPresenters:
Maria G. Morais, RN
PBC Transplant Patient
VP Patient Advocacy
Canadian PBC Society
Toronto, Canada
Link t...
Keeping Up With New Developments in PBC
Tune in to listen as expert faculty, Dr Christopher L. Bowlus and Dr Sonal Kumar, discuss recent developments in treating primary biliary cholangitis (PBC) with new and emerging agents, as well as strategies to integrate these advances into clinical practice.
Topics covered include:
Methods of Assessing PBC Disease ProgressionNewer Agents for Second-line Treatment of PBCPrioritizing Symptom Management and Quality of Life With PBC TreatmentPresenters:
Christopher L. Bowlus, MD
Lena Valenta Professor and Chief
Division of Gastroenterology and Hepatology
School of Medicine
University of California Davis
Sacramento, California
The Pediatric Influenza Vaccine Playbook Podcast: Proven Paths to Prevention
Listen to this podcast featuring highlights from our expert roundtable discussion to learn about the most pressing issues in pediatric influenza vaccines, including current vaccine technologies, recent vaccine uptake and epidemiologic trends, and how to discuss the vast benefits of timely vaccination in pediatric patients with their parents and caregivers. Topics covered include:
Groups at High Risk for ComplicationsGuideline Recommendations for Influenza VaccinationAvailable Seasonal Flu Vaccine Formulations and Their CharacteristicsPractical Considerations for Selecting Pediatric Influenza VaccinesUptake of Influenza Vaccines in Children: Reversing the TrendsPresenters:
Ravi Jhaveri, MD, FIDSA, FPIDS, FAAP
Division Head
...
Beyond Viral Suppression: What’s New in HIV Care for Treatment-Experienced People
Tune in as Princy N. Kumar, MD, MACP, FRCP, and Charlotte-Paige Rolle, MD, MPH discuss the latest in immune recovery, chronic inflammation, and more in the management of treatment-experienced people living with HIV.
Topics covered include:
Immunologic nonresponseTheories around soluble gp120 and antibody-dependent cellular cytotoxicityLatest data from BRIGHTE, RECOVER, and moreFuture DirectionsPresenters:
Princy N. Kumar, MD, MACP, FRCP
Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Tropical Medicine
Vice Dean for Student Affairs
Georgetown University School of Medicine
Washington, DC
Charlotte-Paige Rolle, MD...
Decera Clinical Education Independent Conference Coverage of IDWeek and EACS 2025: HIV Update Podcast
Tune into this podcast to revisit discussions led by global experts, Karine Lacombe, MD, PhD, and Chloe Orkin, MBChB, FRCP, MD, featuring the latest updates on HIV treatment and prevention from the 2025 IDWeek and EACS conferences.
Topics covered include:
Real-world safety and efficacy of long-acting ARTART switch: preferences, treatment satisfaction, changes in weight and metabolic parameters, and HBV reactivation riskInvestigational therapiesUpdates on long-acting PrEP: persistence, use in people with substance use disorder, and coadministration with gender-affirming hormone therapyHIV and STI screening with PrEPSTI preventionTo download the accompanying slides, visit the program page for this ep...
RSV Revealed Podcast: The Role of Diagnostic Testing in Advancing Clinical Care
In this podcast, featuring audio from an expert roundtable video module, listen as 3 multidisciplinary faculty, Tracey Q. Davidoff, MD, FCUCM; Carina Marquez, MD, MPH; and Jeffrey D. Whitman, MD, MS, discuss the benefits of diagnosing respiratory syncytial virus (RSV) and optimal testing strategies. Topics covered include:
The annual burden of RSV and the benefits of diagnosisWhom to test and what diagnostic techniques to useLogistical considerations for implementationPotential benefits of RSV testingFor the full video module and to download the accompanying slides, visit the program page for this episode:
https://bit.ly/3MrXTpI
Presenters:<...
Rebuilding Confidence in Vaccines: Countering Misinformation During Pharmacy Visits
Every day, I hear patients share worries shaped by the growing wave of vaccine misinformation—questions that reveal just how overwhelming today’s “infodemic” has become. In this podcast, I explore what vaccine hesitancy really looks like and how pharmacists can use empathy, strong recommendations, and meaningful dialogue to help rebuild confidence in immunization.
Presenter:
Mary Barna Bridgeman, PharmD, BCPS, BCGP
Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Internal Medicine Clinical Pharmacy Specialist
Robert Wood Johnson University Hospital-New Brunswick
New Brun...
Elevating the Voices of Transgender People Living With HIV
This episode focuses on hearing the voices of transgender people living with HIV and their advocates as they share what matters most to them when it comes to healthcare services and where HIV fits among those priorities. We also consider how these insights can assist healthcare professionals in configuring HIV care to better meet the needs of this key population. Topics addressed include:
Overarching health and well-being priorities within the broader context of everyday life challenges Personal experiences of suboptimal interactions with healthcare services, and their impact on health-seeking behaviorsKey components of a transgender-welcoming healthcare environment Principles of pe...Closing Gaps in STI Care Through Molecular Point-of-Care Testing
Molecular point-of-care testing has the potential to substantially mitigate the impact of sexually transmitted infections (STIs) on personal and public health. Listen in to learn how it may even limit the development of antimicrobial resistance. Topics covered include:
CDC and US Preventive Services Task Force STI screening recommendationsWhether or not laboratory-based STI tests contribute to increasing antibiotic resistanceRole of point-of-care testing and strategies for implementationPresenter:
Jeffrey D. Klausner, MD, MPH
Clinical Professor of Medicine
Population and Public Health Sciences Lead
Infectious Diseases Epidemiology and Applies Studies (I.D.E.A.S.) Initiative<...
Testing Is Treatment: The Power of Routine HIV Screening
The crux of HIV care and prevention is quick and accurate diagnosis. Listen in to learn from Aniruddha (Anu) Hazra, MD, and Dr. Nancy S. Miller about the advantages and potential pitfalls of different HIV testing algorithms to find out which one is best suited for your practice.
Presenters:
Aniruddha (Anu) Hazra, MD
Associate Professor, Section of Infectious Diseases and Global Health
Medical Director, UCM Sexual Wellness Clinic
Director of STI Services, Chicago Center of HIV Elimination
Department of Medicine
University of Chicago
Chicago, Illinois
Nancy S...
Optimizing Antibiotics in Acute Bacterial Skin and Skin Structure Infections for Today
Listen in as experts Thomas P. Lodise, PharmD, PhD, and George Sakoulas, MD, FIDSA, explore tailored antibiotic strategies for diverse patients with acute bacterial skin and skin structure infections (ABSSSIs). Their insightful discussion focuses on antibiotic developments that followed publication of the IDSA practice guidelines in 2014 and the challenges unique to ABSSSIs, including a lack of determined bacterial etiology for many cases.
Presenters
Thomas P. Lodise, PharmD, PhD
Professor
Albany College of Pharmacy and Health Sciences
Infectious Diseases Clinical Pharmacy Specialist
Stratton VA Medical Center
Albany, New York
Geo...
Overcoming Misconceptions About Candidacy for Switch: Barriers to Optimizing ART in People Living With HIV and Viral Suppression
Look beyond viral suppression to learn how people living with virologically suppressed HIV may still be candidates for antiretroviral therapy (ART) switch to improve treatment satisfaction and quality of life. Topics covered include:
Reasons to consider regimen optimization in setting of viral suppressionAvailable switch regimens, including 2-drug regimens and long-acting ARTApproaches to assess for resistance before starting long-acting cabotegravir plus rilpivirine DHHS recommendations on proviral DNA genotypingART optimization strategies for patients living with viral suppression and history of underlying resistancePresenters:
Brian R. Wood, MD
Professor of Medicine
Division of Allergy and Infectious D...
Modern S. maltophilia Management: Current Concepts for Best Outcomes
Join Ryan K. Shields, PharmD, MS, in the third of 3 podcasts from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients” to learn how to optimize antimicrobial regimens and develop evidence-based antibiotic management plans for complex infections caused by carbapenem-resistant bacteria. Topics covered in this segment include:
Mechanisms of resistance in S. maltophiliaCurrent frontline therapies2024 IDSA guidance for treatmentPresenter:
Ryan K. Shields, PharmD, MS
Associate Professor of Medicine
Co-Director, Center for Innovative Antimicrobial Therapy
University of Pittsburgh
Co-Director, Antibiotic Management Program
UPMC Presbyterian Hospi...
Carbapenem Resistance Revisited: Reassessing Our Antibiotics of Choice
Join Marin H. Kollef, MD in the first of 3 podcasts from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients” to learn how to optimize antimicrobial regimens and develop evidence-based antibiotic management plans for complex infections caused by carbapenem-resistant bacteria. Topics covered in this segment include
Antimicrobial resistance mechanismsDiagnostic strategies for identifying resistanceAntibiotic selection strategiesPreferred and alternative antibiotics according to guideline recommendationsPresenter:
Marin H. Kollef, MD
Virginia E. and Sam J. Golman Chair in Respiratory Intensive Care Medicine
Professor of Medicine
Division of Pulmonary & Critical Care...
DTR-P. aeruginosa: Pathways to Overcoming Diverse Resistance Profiles
Join Ryan K. Shields, PharmD, MS, in the second of three recap podcasts taken from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients.” Learn how to optimize antimicrobial regimens and develop evidence-based antibiotic management plans for complex infections caused by carbapenem-resistant bacteria. Topics covered in this segment include:
The diverse mechanisms of β-lactam resistanceThe effect of resistance mechanisms on susceptibility to antimicrobials 2024 IDSA guidance for treatmentConsiderations for antibiotic selectionThe role of combination therapyPresenter:
Ryan K. Shields, PharmD, MS
Associate Professor of Medicine
Co-Director, Center for Innovat...
Overcoming Fear of Virologic Failure: Barriers to Optimizing ART in People Living With HIV and Viral Suppression
Fear of virologic failure is a major barrier to ensuring that people living with virally suppressed HIV are receiving the most optimal antiretroviral therapy (ART) regimen for them. Stream this Medical Minute to learn more about key guideline recommendations regarding ART switch and reassuring clinical data regarding efficacy, tolerability, and quality of life associated with switching a suppressive ART regimen. Topics covered include:
Efficacy of switching to 2-drug oral ART: real-world evidenceReal-world analyses of virologic failure with switch to long-acting cabotegravir plus rilpivirinePatient selection to reduce risk of virologic failure with switch Regimen-specific switch considerationsPresenters:
The Role of Antimicrobial Stewardship Programs in Implementing Rapid Phenotypic AST
Rapid phenotypic antimicrobial susceptibility testing (AST) significantly reduces time to actionable results and can improve antibiotic decision-making for patients with bloodstream infections. Listen in to learn from Michael P. Veve, PharmD, MPH, how to optimally integrate rapid phenotypic AST into clinical practice, including incorporation into your existing antimicrobial stewardship workflow. Topics covered include:
Considerations for implementationDecision-making steps for implementationThe role of antimicrobial stewardship programs in AST workflowPresenter:
Michael P. Veve, PharmD, MPH
Clinical Associate Professor
Department of Pharmacy Practice
Eugene Applebaum College of Pharmacy and Health Sciences
Wayne State University<...
Integration of Genotypic RDT With Rapid Phenotypic AST for Bloodstream Infections
Unnecessary broad-spectrum antibiotics can drive antimicrobial resistance and cause adverse events, whereas inadequate antibiotic coverage is linked to increased mortality and length of stay for patients with bloodstream infections (BSIs). Listen now to learn from Jose Alexander, MD, D(ABMM), CIC, FCCM, SM/MB(ASCP), how to use rapid genotypic and phenotypic antimicrobial susceptibility testing results to inform antibiotic selection for patients with gram-negative BSIs. Topics covered include:
Typical patterns of intrinsic antibiotic susceptibility and resistance in EnterobacteralesMechanisms of resistance in gram-negative bacteriaGenotypic rapid diagnostic tests for BSIsResistance markers for earlier targeted therapyRapid phenotypic antimicrobial susceptibility test platforms...The Ongoing Challenge of Antimicrobial Selection for Bloodstream Infections
Sepsis and bloodstream infections (BSIs) are common and cause millions of deaths each year, with a disproportionate burden in low-income and middle-income countries. Tune in to learn from Jasmine R. Marcelin, MD, FACP, FIDSA, how inadequate antibiotic coverage can be linked to increased mortality and length of stay and how unnecessary broad-spectrum antibiotics can drive antimicrobial resistance. Topics covered include:
The worldwide burden of sepsis and BSIsThe ongoing threat of antimicrobial resistanceUS and global health disparities in sepsis, BSI, and antimicrobial resistanceBarriers toward optimizing antibiotic use in BSIsPresenter:
Jasmine R. Marcelin, MD, FACP, FIDSA<...
Role of Pharmacists in PrEP Delivery
Stream this podcast to learn from experts Tessa Rife-Pennington, PharmD, BCGP, and Frank North, PharmD, MPA, DPLA, DASPL, how specialty pharmacists can apply practical strategies within different pharmacy settings to overcome barriers to PrEP use, especially among underserved patient subpopulations. Topics covered include:
PrEP candidacy Selection of individualized regimensKey barriers to PrEP useStrategies for overcoming key barriers to PrEP accessEvolving state-based legislation on PrEP provision by pharmacistsModels of pharmacy-managed PrEPStrategies for addressing inequities in PrEP careComprehensive HIV prevention servicesPresenters:
Tessa Rife-Pennington, PharmD, BCGP
Dr. Dawn K. Smith HIV Prevention Clinical Fellow
American Ac...
Forging a Path Back to HIV Care
In this episode, expert patient navigators Shellye Jones and Lauren Jackson discuss the key take-home points of our online educational program on facilitating engagement in HIV care and propose a framework for effectively retaining people in care. Topics covered include:
How to approach a patient with complex barriers to engagement in healthcareResources for staying in care, such as wraparound servicesSetting SMART goals and formulating action plans with patientsDeconstructing stigma and implementing a trauma-informed approach to carePresenters:
Shellye Jones, MSW, LCSW
Clinical Supervisor
Charles R. Drew University, Drew CARES
Los Angeles, California
Overcoming Reluctance to Change as a Barrier to Optimizing ART for People Living With HIV and Viral Suppression
Don’t settle! Listen in to learn how a proactive approach to ART switch can improve treatment satisfaction and quality of life for people living with virologically suppressed HIV. Topics covered include:
International AIDS Society (IAS) USA and European AIDS Clinical Society (EACS) Guidance on Switching ART With Viral SuppressionConsiderations for switching to a 2-drug regimen or long-acting ARTMethods for assessing patient satisfaction with their current ART regimenPresenters:
Monica Gandhi, MD, MPH
Director, UCSF-Bay Area Center for AIDS Research (CFAR)
Professor of Medicine and Associate Chief, Division of HIV, Infectious Diseases, and Gl...
HIV “Blips”: What They Are (and Aren’t)
Detectable HIV-1 RNA (viral load) can seem very worrisome for people living with HIV who are receiving antiretroviral therapy (ART) and for their healthcare professionals. Tune in to learn how Brian R. Wood, MD, differentiates HIV-1 RNA “blips” from persistent low-level viremia and from virologic failure, and how he handles each scenario.
Presenter:
Brian R. Wood, MD
Professor of Medicine
Division of Allergy and Infectious Diseases
University of Washington
Seattle, Washington
Link to full program:
https://bit.ly/4nS7rYE
Get access to all of our new po...
Individualizing Care for Treatment-Experienced People With HIV
Tune into this podcast from Dr Clíona Ní Cheallaigh to learn how to provide person-centered care for treatment-experienced people with HIV. Gain strategies to address each individual’s specific history and needs while considering the potential impact of comorbidities and other health challenges. Topics covered include:
Individualizing Antiretroviral Regimens for Treatment-Experienced People With HIVStrategies to Improve Adherence and Addressing Barriers to Engagement in CarePerson-Centered, Trauma-Informed CareResistance Testing in the Setting of Virologic FailureSelection of ARVs With a Failing RegimenPresenters:
Clíona Ní Cheallaigh, MB, MRCP, PhD
Consultant Physician
Inclusion Health Services
St Jam...
Clinical Scenarios Podcast: A Deep Dive Into Refractory CMV Infections
In this podcast, expert faculty Atul Humar, MD, FRCP (C), and Camille Kotton, MD, FIDSA, FAST, take a deep dive into complex clinical scenarios and explore designing antiviral regimens for refractory CMV infections to minimize antiviral toxicities and maximize efficacy. Topics covered include:
Management for suspected drug-resistant CMV infection Illustrative patient cases Gene mutations in CMV
Presenters:
Atul Humar, MD, FRCPC, FAST
Professor
Department of Medicine
University of Toronto
Eaton Family Chair in Transplant Infectious Diseases
Ajmera Transplant Centre
University Health Network
Toronto, Canada
Cami...
Charting the Course Podcast: Antivirals for Refractory CMV Infections
Learn to appropriately modify antiviral therapy in solid organ transplant recipients with treatment-refractory cytomegalovirus (CMV) infections with expert faculty, Atul Humar, MD, FRCP (C). Topics covered include:
Comparisons of available CMV antiviral therapies:Ganciclovir, valganciclovir, foscarnet, cidofovir, maribavirConsiderations for renal function monitoring with ganciclovir and valganciclovirA treatment algorithm for relapsed/refractory CMVThe latest clinical trial data and guideline recommendationsPresenter:
Atul Humar, MD, FRCP (C)
Professor
Department of Medicine
University of Toronto
Eaton Family Chair in Transplant Infectious Diseases
Ajmera Transplant Centre
University Health Network
Toronto, Canada
L...
Soundings Podcast: Identifying Refractory CMV Infections in Transplant Settings
Tune in to learn the fundamentals for timely identification of refractory cytomegalovirus (CMV) infections following solid organ transplantation from expert faculty, Camille Kotton, MD, FIDSA, FAST. Topics covered include:
Direct and indirect effects of CMV infectionRisk factors for resistant/refractory CMVDefining resistant/refractory CMVPresenter:
Camille Kotton, MD, FIDSA, FAST
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Infectious Diseases Division
Mass General Brigham Endowed Cancer Chair IV
Massachusetts General Hospital
Associate Professor, Harvard Medical School
Boston, Massachusetts
Link to full program:
http://bit.ly/4lOa2kA
The Patient Angle: Individualized Approaches for Managing CMV
Listen in as Dr Marcus Pereira and Dr Raymund R. Razonable explore strategies for individualization of CMV management in high-risk kidney transplant recipients. Topics include:
Risk factors and prevention of late-onset CMV diseaseEarly detection of late CMV infectionCMV cell-mediated immunity monitoringPrimary and secondary prophylaxis
Presenters:
Marcus Pereira, MD, MPH, FAST
Associate Professor of Medicine
Director of Clinical Services, Division of Infectious Diseases
Medical Director, Transplant Infectious Disease Program
Columbia University Irving Medical Center
New York, New York
Raymund R. Razonable, MD, FIDSA, FAST
Professor of Medicine
The Viral Angle: CMV in Kidney Transplantation
Listen in as Dr Marcus Pereira and Dr Raymund R. Razonable discuss the fundamentals of cytomegalovirus (CMV) in kidney transplant recipients. Topics include:
CMV pathogenesisDirect and indirect effects of CMV infection Overview of patient risk factorsCMV risk based on serologic status
Presenters:
Marcus Pereira, MD, MPH, FAST
Associate Professor of Medicine
Director of Clinical Services, Division of Infectious Diseases
Medical Director, Transplant Infectious Disease Program
Columbia University Irving Medical Center
New York, New York
Raymund R. Razonable, MD, FIDSA, FAST
Professor of Medicine
Division of Infectiou...
Syndromic Testing Podcast: Gastrointestinal and Joint Infections
Listen in as Dr Trevor Van Schooneveld explores rapid syndromic testing for gastrointestinal and joint infections and discusses how to apply best practices for diagnostic and antimicrobial stewardship in syndromic testing.
Topics covered include:
Who should be tested for infectious diarrheaTypes of gastrointestinal syndromic panelsTypes of syndromic panels for joint infectionsReal-world applications for joint syndromic panelsPresenters:
Trevor Van Schooneveld, MD
Professor, Division of Infectious Diseases
Medical Director, Antimicrobial Stewardship Program
Department of Internal Medicine
University of Nebraska Medical Center
Omaha, Nebraska
Link to full program:
The Antiviral Angle: Leveraging the Full CMV Armamentarium
Listen in as Dr Marcus Pereira discusses how to design cytomegalovirus (CMV) antiviral regimens for high-risk kidney transplant recipients to mitigate the impact of infection while minimizing drug toxicities. Topics include:
Strategies for CMV prevention: prophylaxis, preemptive therapy, and hybrid methodsCharacteristics of available antiviral drugsMonitoring considerations for antiviralsPresenters:
Marcus Pereira, MD, MPH, FAST
Associate Professor of Medicine
Director of Clinical Services, Division of Infectious Diseases
Medical Director, Transplant Infectious Disease Program
Columbia University Irving Medical Center
New York, New York
Link to full program:
http://bit.ly/41ejruC...
Heartbreak to Hope: My Journey With Meningitis Vaccine Advocacy
Join Alicia Stillman of the American Society for Meningitis Prevention, as she shares a very personal story of loss that might change how you view meningitis vaccination.
Presenter:
Alicia Stillman, MBA, MPH
Patient Advocate
Co-Executive Director, American Society for Meningitis Prevention
Executive Director, Emily Stillman Foundation
Detroit, Michigan
Link to full program:
https://bit.ly/4mYvTXQ
Register for the practical symposium:
https://bit.ly/4mUOsvV
Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple...
